Tradition Wealth Management’s Biogen BIIB Stock Holding History

Tradition Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80	Closed	-$21K	–	463
2023 Q4	$21K	Buy	80 +1	+1%	+$246	﹤0.01%	826
2023 Q3	$20K	Sell	79 -2	-2%	-$535	﹤0.01%	841
2023 Q2	$23K	Buy	81 +1	+1%	+$298	﹤0.01%	838
2023 Q1	$22K	Hold	80	–	–	﹤0.01%	809
2022 Q4	$22K	Buy	80 +1	+1%	+$282	﹤0.01%	730
2022 Q3	$21K	Buy	79 +1	+1%	+$212	﹤0.01%	738
2022 Q2	$16K	Hold	78	–	–	﹤0.01%	687
2022 Q1	$16K	Hold	78	–	–	﹤0.01%	765
2021 Q4	$19K	Hold	78	–	–	﹤0.01%	738
2021 Q3	$22K	Hold	78	–	–	﹤0.01%	695
2021 Q2	$27K	Hold	78	–	–	﹤0.01%	683
2021 Q1	$22K	Hold	78	–	–	﹤0.01%	615
2020 Q4	$19K	Buy	+78	New	+$20.1K	﹤0.01%	593

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tradition Wealth Management's BIIB Position: Q1 2024 in Review

Tradition Wealth Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 80 shares — an estimated $21K sold.

Tradition Wealth Management first reported a position in BIIB in Q4 2020 and held it in 13 quarters. The position peaked at $27K in Q2 2021. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Tradition Wealth Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
Tradition Wealth Management sold 80 Biogen shares in Q1 2024, an estimated $21K.
Tradition Wealth Management first reported a position in Biogen in Q4 2020 and held it in 13 quarters.
Tradition Wealth Management's Biogen position peaked at $27K in Q2 2021.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.